Literature DB >> 9410472

A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England.

G Willis1, B A Jennings, E Goodman, I W Fellows, J Z Wimperis.   

Abstract

We have examined normal individuals and all the patients currently being treated for hemochromatosis at the Norfolk and Norwich hospital for mutations in the HLA-H gene. We found a gene frequency in 200 normal subjects for teh 845A (C282Y) allele of 0.085, corresponding to a carrier frequency of 17% which is among the highest reported anywhere in the world. The frequency for the less penetrant 187G (H63D) allele was 0.16 among 58 of the normal subjects, which corresponds to a carrier frequency of 32%. All 18 hemochromatosis patients were homozygous for the 845A allele which is not significantly different from other reports in our subset of 12 unrelated patients. These findings present a snapshot of a relatively stable population containing a predicted 3,500 individuals homozygous for the 845A allele but not diagnosed with hemochromatosis. This population will be an excellent model for studies on the penetrance of the 845A homozygous genotype and population screening.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9410472     DOI: 10.1006/bcmd.1997.0145

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

1.  [Genetics and quaternary prevention. The example of haemochromatosis].

Authors:  J Gérvas; M Pérez Fernández
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

2.  Incidence of liver disease in people with HFE mutations.

Authors:  G Willis; J Z Wimperis; R Lonsdale; I W Fellows; M A Watson; L M Skipper; B A Jennings
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

3.  Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.

Authors:  M Bhavnani; D Lloyd; A Bhattacharyya; J Marples; P Elton; M Worwood
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

4.  Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

Authors:  C D J Evans; K A Oien; R N M MacSween; P R Mills
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

5.  Prevalence of 845G>A HFE mutation in Slavic populations: an east-west linear gradient in South Slavs.

Authors:  Grazyna Adler; Jeremy S Clark; Beata Łoniewska; Andrzej Ciechanowicz
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

6.  Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study.

Authors:  Gavin Willis; Vicky Bardsley; Ian W Fellows; Ray Lonsdale; Jennie Z Wimperis; Barbara A Jennings
Journal:  BMC Gastroenterol       Date:  2005-06-01       Impact factor: 3.067

7.  The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic.

Authors:  Kathleen M Heath; Jacob H Axton; John M McCullough; Nathan Harris
Journal:  Am J Phys Anthropol       Date:  2016-01-22       Impact factor: 2.868

8.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.